KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Gilead Sciences (GILD) Consolidated Net Income (2016 - 2025)

Historic Consolidated Net Income for Gilead Sciences (GILD) over the last 17 years, with Q3 2025 value amounting to $3.1 billion.

  • Gilead Sciences' Consolidated Net Income rose 14357.54% to $3.1 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $8.1 billion, marking a year-over-year increase of 707699.12%. This contributed to the annual value of $479.0 million for FY2024, which is 9146.47% down from last year.
  • Gilead Sciences' Consolidated Net Income amounted to $3.1 billion in Q3 2025, which was up 14357.54% from $2.0 billion recorded in Q2 2025.
  • Over the past 5 years, Gilead Sciences' Consolidated Net Income peaked at $3.1 billion during Q3 2025, and registered a low of -$4.2 billion during Q1 2024.
  • Its 5-year average for Consolidated Net Income is $1.2 billion, with a median of $1.5 billion in 2021.
  • As far as peak fluctuations go, Gilead Sciences' Consolidated Net Income surged by 810000.0% in 2023, and later plummeted by 52388.21% in 2024.
  • Gilead Sciences' Consolidated Net Income (Quarter) stood at $376.0 million in 2021, then soared by 334.31% to $1.6 billion in 2022, then dropped by 13.29% to $1.4 billion in 2023, then increased by 25.85% to $1.8 billion in 2024, then skyrocketed by 71.27% to $3.1 billion in 2025.
  • Its Consolidated Net Income was $3.1 billion in Q3 2025, compared to $2.0 billion in Q2 2025 and $1.3 billion in Q1 2025.